Science Stories
Extensive-stage small cell lung cancer remains one of the most aggressive and difficult-to-treat cancers, with most patients relapsing within months of initial therapy. Maintenance therapy may turn the period of stability after their first treatment into an opportunity to extend response and delay relapse.
Given the limited recognition of idiopathic hypersomnia, there is not substantial data on the burden of symptoms on those living with the disorder. Recent real-world evidence from a self-reported survey published in Nature and Science of Sleep reveals more insights around idiopathic hypersomnia symptoms and patients’ satisfaction with treatment regimens.
Dravet syndrome is a rare, severe, lifelong form of treatment-resistant epilepsy that typically begins in the first year of life.
The onset of cardiovascular events and risk factors is high among those living with narcolepsy, even among patients who do not have a history of these cardiovascular conditions. Learn more about the key findings of the CV-BOND study, recently presented by Rami H. Ben-Joseph, Ph.D., head of big data real world evidence at Jazz.